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Tuning chemotactic responses with synthetic multivalent ligands
Jason E Gestwicki, Laura E Strong and Laura L Kiessling
Background: Multivalent ligands have been used previously to investigate the
role of ligand valency and receptor clustering in eliciting biological responses.
Studies of multivalent ligand function, however, typically have employed divalent
ligands or ligands of unde¢ned valency. How cells respond to multivalent ligands
of distinct valencies, which can cluster a signaling receptor to different extents,
has never been examined. The chemoreceptors, which mediate chemotactic
responses in bacteria, are localized, and clustering has been proposed to play a
role in their function. Using multivalent ligands directed at the chemoreceptors, we
hypothesized that we could exploit ligand valency to control receptor occupation
and clustering and, ultimately, the cellular response.
Results: To investigate the effects of ligand valency on the bacterial chemotactic
response, we generated a series of linear multivalent arrays with distinct
valencies by ring-opening metathesis polymerization. We report that these
synthetic ligands elicit bacterial chemotaxis in both Escherichia coli and Bacillus
subtilis. The chemotactic response depended on the valency of the ligand; the
response of the bacteria can be altered by varying chemoattractant ligand
valency. Signi¢cantly, these differences in chemotactic responses were related to
the ability of the multivalent ligands to cluster chemoreceptors at the plasma
membrane.
Conclusions: Our results demonstrate that ligand valency can be used to tune
the chemotactic responses of bacteria. This mode of regulation may arise from
changes in receptor occupation or changes in receptor clustering or both. Our
data implicate changes in receptor clustering as one important mechanism for
altering cellular responses. Given the diverse events modulated by changes in the
spatial proximity of cell surface receptors, our results suggest a general strategy
for tuning biological responses.
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Introduction
Ligand valency (the number of biologically active epitopes
a multivalent ligand presents) has been shown to be im-
portant for regulating many biological processes [1,2]. In
systems ranging from growth factor receptor-mediated sig-
naling to cellular recognition, increasing the valency of the
ligand increases the resultant biological response [3^12].
The increased activities of multivalent over monovalent
ligands have been attributed, in some cases, to the ability
of the multivalent ligand to cluster cell surface receptors,
thereby initiating downstream signal transduction re-
sponses [4,13^16]. Multivalent ligands can form simultane-
ous contacts with multiple receptors, forcing these recep-
tors into proximity. Clusters of certain receptors have been
shown to be highly active in transducing signals due to
organization of cytoplasmic components [6,16] and favor-
able receptor^receptor interactions [4,13]. Moreover, li-
gands of different valencies could result in varying levels
of receptor occupation. We hypothesized that the valency
of a ligand could be used to modulate cellular responses.
To explore the role of ligand valency in regulating cellular
responses, a method of generating de¢ned multivalent li-
gands is required. De¢ned molecules that have been used
to investigate multivalent events are typically divalent,
such as antibodies and, more recently, low molecular
weight synthetic ligands [17^19]. Yet, many interesting
biological systems exploit multivalent interactions of high-
er order valencies [1]. The generation of de¢ned ligands of
a wide range of valencies would facilitate the systematic
study of multivalent interactions. Synthetic methods can
be used to add epitopes to a preformed carrier, as is
done commonly with bovine serum albumin^hapten con-
jugates [20]. Multivalent receptor^ligand interactions are
complex, however, and parameters such as ligand density,
orientation and spacing may also modulate the response of
receptors to ligand binding. With available carrier conju-
gates, the effects of changes in ligand valency cannot be
easily dissected from those due to changes in epitope pre-
sentation (i.e. residue density and spacing). Ideally, the
chosen synthetic method should allow the variation of in-
dividual parameters. Linear synthetic multivalent scaffolds,
such as acrylamide polymers or polylysine, are uniform in
presentation but are not of de¢ned lengths [21,22]; conse-
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quently, it is dif¢cult to ascribe the responses they elicit to
speci¢c changes in valency. Ring-opening metathesis poly-
merization (ROMP) can be used to create linear multiva-
lent materials of distinct lengths with pendant polar, bio-
logically relevant recognition epitopes [23^26]. This
method has been used previously to create multivalent
inhibitors of cell function [27,28]. ROMP-derived materials
possess characteristics suitable for the creation of molecules
to explore the relationship between ligand valency and
cellular responses [22]. To investigate whether ligand va-
lency can be used to tune a biological response, we exam-
ined the abilities of galactose-bearing polymers of differing
valencies to promote bacterial chemotaxis.
The molecular events leading to bacterial chemotaxis have
been well studied, and the process has served as a general
model for receptor-mediated responses [29^32]. During
chemotaxis in Escherichia coli (E. coli), chemoattractants,
such as sugars and amino acids, and chemorepellents are
recognized by speci¢c receptors at the bacterial plasma
membrane [33]. For our investigations of multivalent li-
gand activity, we selected galactose as a chemoattractant.
The related compound, L-methyl galactopyranoside, is also
a chemoattractant, indicating that the attachment of sub-
stituents at the anomeric position of galactose does not
abolish its chemotactic activity [34]. This observation sug-
gests that galactose residues could be tethered through an
anomeric linker to create a multivalent display. For galac-
tose-mediated signaling, the saccharide must bind to the
soluble periplasmic glucose/galactose-binding protein
(GGBP), which, in turn, interacts with the galactose-sens-
ing chemoreceptor, Trg [34,35]. Galactose-GGBP binding
to Trg initiates a signaling pathway that results in reversal
of the direction of £agellar spin allowing the bacteria to
swim towards the nutrient [29,30,36].
Bacterial chemotaxis requires an extremely sensitive sens-
ing system with a broad dynamic range. Through their
chemoreceptors, bacteria can detect very small changes in
ligand concentration over many orders of magnitude
[37,38]. A recent mathematical model proposed by Bray
et al. to explain this remarkable feature suggests that signal
transduction is regulated by changes in lateral clustering of
the chemoreceptors [39^41]. In this model, clusters of bac-
terial chemoreceptors exchange ligand binding information,
such that receptor clusters are more active in signal gen-
eration than individual receptors [39,41]. We hypothesized
that ligands with distinct valencies would be able to differ-
entially cluster the receptors and that this alteration in
receptor clustering would in£uence the chemotactic re-
sponse: larger clusters should give rise to larger signals.
Here, we report that ligand valency can be used to tune
the chemotactic responses of both E. coli and Bacillus sub-
tilis. Further, we provide evidence that multivalent ligands
of different valencies differentially cluster the bacterial
chemoreceptors. Our results suggest that the output re-
sponse due to receptor engagement is modulated by re-
ceptor clustering.
Results and discussion
ROMP-derived polymers can induce chemotactic
responses
Galactose-bearing ligands of varying valencies were gener-
ated using ROMP (Figure 1). The galactose residues in the
multivalent ligands are tethered to the backbone via a
short linker. The attachment of this linker did not prevent
binding to puri¢ed GGBP, as the interaction of monomer 1
was at least as favorable as that of galactose in an in vitro
binding assay (data not shown). It was important, however,
to determine whether galactose presented in this manner
would serve as an attractant in vivo.
We ¢rst sought to determine whether functionalized galac-
tose derivatives, such as monovalent 1 and multivalent 3,
possess chemotactic activity by monitoring the behavioral
response of E. coli to these ligands. The locomotion be-
havior of E. coli occurs in two modes, running and tum-
bling, which are de¢ned by the direction of the £agellar
spin and, ultimately, the signal transduction response that
arises from interaction of the chemoreceptor with the li-
gand [42]. Bacteria in the presence of an attractant will
undergo prolonged running responses with low tumbling
frequency [42,43]. To observe the effects of synthetic li-
gands on tumbling frequency, E. coli were treated with
galactose or galactose-bearing ligands, and bacterial motion
was recorded and analyzed using the method of Sager et al.
[44]. The tumbling frequency was assessed by averaging
the mean angular velocity of the paths obtained in the ¢rst
5^15 s after addition of attractant (Figure 2). As expected,
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Figure 1. Structure of the galactose monomer 1 and the ROMP-
derived multivalent arrays displaying galactose 2^4. Emulsion
polymerization conditions ((a) [Cy3P]2Cl2Ru = CHPh,
dodecyltrimethylammonium bromide, water, 1,2-dichloroethane,
heat; (b) ethyl vinyl ether) were used to convert 1 to the series of
oligomers 2^4 [24,55]. The valency (n) is calculated as described
in the Materials and methods section.
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when bacteria were treated with increasing concentrations
of galactose, the mean angular velocity decreased, an in-
dication of a running response. Treatment with monova-
lent compound 1 produced similar effects, indicating that
the anomeric substituent in 1 did not preclude chemotactic
activity. Multivalent compound 3 was more active than
monovalent 1 or unmodi¢ed galactose. It induced a low
mean angular velocity even at very low (e.g. 0.001 mM)
galactose residue concentrations. (For multivalent ligands,
we used the galactose residue concentration not the molar
concentration of ligand for comparisons.) The response of
the bacteria to 3 at 0.01 mM galactose residue concentra-
tion was comparable to that obtained at a 100-fold higher
(1 mM) concentration of monomer 1. Signi¢cantly, these
differences in concentration of maximum activity between
the monomer 1 and multivalent 3 provided key evidence
that ligand valency affects chemotactic activity.
The valency of the ligand determines the chemotactic
response
To further explore the relationship between ligand valency
and chemotactic response, E. coli were subjected to con-
centration gradients of compounds 1^4 in capillary accumu-
lation assays [45]. In this procedure, attractants are eval-
uated by determining the concentration at which the
maximum chemotactic response is achieved and the num-
ber of bacteria that accumulate at this maximum [34]. We
hypothesized that increasing ligand valency in these assays
would increase the potency of the response.
When compounds 1^4 were used as attractants in the capil-
lary accumulation assay, oligomer 2 was no more active
than monovalent 1; both elicited a maximum chemotactic
response at 1 mM (Figure 3a). The activity of these com-
pounds was speci¢c to the pendant saccharide residue, as
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Figure 2. Results of video microscopy motion analysis experiments. (a) Bacteria were treated with buffer alone, galactose, or compound 1
or 3, at the indicated saccharide concentrations. The results represent the average from at least ¢ve independent experiments performed
in triplicate. Error bars represent the deviation between per-second averages during the 10 s interval (see Materials and methods section).
Asterisks represent data for which representative video documentation is supplied (http://www.chem.wisc.edu/Vkiessling/bact^vid).
(b) Selected sample paths for bacteria treated with buffer alone, galactose, or compound 1 or 3. Sample paths are derived from the motion
of representative bacterium from a population treated with buffer alone, 1 mM galactose, 1 mM 1 or 0.1 mM 3.
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compound 1 was not a chemoattractant for ggbp (AW550
and AW543) or trg (AW701) E. coli mutants (Figure 4).
These results indicate that the ligands act speci¢cally
through the galactose-sensing machinery. The similarity
of bacterial responses to 1 and 2 can be rationalized by a
comparison of their lengths and binding capabilities. Mo-
lecular modeling studies indicate that the maximum length
of oligomer 2 is approximately 50 Aî [23]; consequently, it
would be unlikely that this agent could cluster the chemo-
receptors, which have been found to be approximately 90
Aî apart [46]. Compound 2 displays a higher local concen-
tration of galactose to the receptor, however, the similarity
in activities of 1 and 2 indicates that a high local concen-
tration of attractant does not give rise to increased chemo-
tactic activity. In contrast, the longer oligomers 3 and 4,
predicted by molecular modeling to be capable of cluster-
ing the receptors, were more potent. The concentrations of
maximum chemotaxis were lower; the maximum for 3 is at
a galactose residue concentration of 0.25 mM and the max-
imum for 4 is at a galactose residue concentration of 0.10
mM (Figure 3b). The ligands of higher valency (3 and 4),
therefore, induce chemotaxis at low concentrations. The
systematic shifts in the concentrations of maximum che-
motaxis indicate that bacterial response can be altered in a
predictable manner simply by changing the mode of ligand
presentation.
The number of E. coli accumulated in assays employing 1^
4 (see Figure 3) is less than that when galactose is used as
an attractant (120,000 bacteria [34]), despite the observed
potency of these ligands in the video assays (see Figure 2).
Capillary accumulation assays depend on proper bacterial
reorientations to travel into the capillary for collection. The
potency of these ligands may disrupt the ability of bacteria
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Figure 3. Results of E. coli capillary accumulation assays. The
number of bacteria accumulated is plotted versus the
concentration of the attractant calculated on a saccharide residue
basis. (a) Results are shown for capillaries ¢lled with buffer alone
(black), 1 (green) and 2 (red) or (b) buffer alone (black), 3 (blue)
and 4 (pink) at the indicated concentrations. The thin vertical line
at 1 mM indicates the concentration of maximum chemotaxis for
the monomeric compound 1. The concentrations used in this
assay are not directly comparable to those used in the motion
analysis experiments (see Figure 2), because the gradient formed
in the capillary assay is not de¢ned. Results are the average of
three to six experiments performed in duplicate and error bars
represent a single standard deviation. Partial permeabilization was
required to obtain chemotaxis towards 4 and was utilized for all
experiments [57].
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Figure 4. Disruption of galactose-sensing abrogates chemotaxis
towards compound 1. Capillary chemotaxis assays were
performed using mutant E. coli strains AW550 (ggbp, blue),
AW543 (ggbp, green) and AW701 (trg, black). Compound 1 was
used as the attractant. Results obtained with chemotactically wild-
type E. coli strain AW405 are shown for comparison (red).
Results are the average of at least ¢ve trials performed in
duplicate and error bars represent single standard deviations.
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to reorient, decreasing the apparent number of bacteria
accumulated. At a given saccharide residue concentration
of a multivalent ligand, fewer molecules are present to
activate the receptors, and these molecules must traverse
the outer membrane. These features of the system may
also contribute to the decreased numbers of bacteria accu-
mulated.
To test the generality of the observed valency-dependent
differences in chemotactic activities and to investigate the
role of membrane permeability in responses to our ligands,
we conducted chemotactic experiments in B. subtilis. B.
subtilis is a Gram-positive bacterium that, like Gram-nega-
tive E. coli, is able to respond to saccharide chemoattrac-
tants [47,48]. In the case of B. subtilis, the multivalent li-
gands can directly interact with saccharide-sensing
receptors, without having to ¢rst traverse the outer mem-
brane. B. subtilis does not respond to galactose, but glucose
is a chemoattractant for these bacteria [47]. When glucose-
bearing compounds were introduced to B. subtilis in the
capillary accumulation assay, they were effective chemoat-
tractants. The chemotactic responses to ligands were
shown to depend on ligand valency: monomer 5 elicited
maximum activity at 1 mM, oligomer 6 at a saccharide
residue concentration of 0.1 mM (10-fold more active
than monomer 5) and oligomer 7 at a saccharide residue
concentration of 0.01 mM (100-fold more active than
monomer 5; Figure 5). Glucose had a maximal activity at
0.5 mM. In analogy to our observations with E. coli, as the
valency of the ligand increases, the saccharide residue con-
centration of maximum chemotaxis decreases. Signi¢cantly,
the number of bacteria accumulated towards 5^7 was com-
parable to the number accumulated when unmodi¢ed glu-
cose was used as the attractant. Consistent with previous
reports on the activity of galactose, galactose-bearing li-
gands (such as 1) were not chemoattractants for B. subtilis
(data not shown) [47], further suggesting that the ROMP-
derived ligands were acting speci¢cally. Together, our re-
sults indicate that in evolutionarily divergent E. coli and
B. subtilis the valency of the attractant can in£uence che-
motactic responses.
Multivalent compounds can cluster bacterial
chemoreceptors
To determine directly whether multivalent ligands can in-
£uence chemoreceptor clustering, £uorescence microscopy
experiments were performed to visualize changes in recep-
tor organization upon treatment with ligand. It has been
shown that wild-type E. coli localize chemoreceptors to
their poles and that inactivation of the structural protein,
CheW, results in a random distribution of chemoreceptors
on the cell [49]. Using cheW mutants, we studied the ability
of ROMP-derived arrays to localize the chemoreceptors.
Bacteria were treated with 1, 3 or 4, ¢xed and labeled
with an antibody to the bacterial chemoreceptors (anti-
Tsr). Monovalent compound 1 had no effect on receptor
distribution, but multivalent compounds 3 and 4 were ob-
served to cluster the chemoreceptors (Figure 6). As antici-
pated, receptor clusters in the cheW cells occurred at seem-
ingly random locations, in contrast to the polar localization
observed in the wild-type bacteria. Receptor clustering was
more pronounced in the case of cells treated with the
longer oligomer 4 than with 3, a result that is consistent
with the differences in chemotactic activities of the li-
gands. The results of these experiments indicate that
ROMP-derived multivalent compounds can induce recep-
tor clustering. In addition, they suggest that changes in
clustering can give rise to changes in chemotactic re-
sponses.
To ascertain whether the multivalent ligands were altering
directly the clustering of the chemoreceptors in the bacte-
rial membrane, we generated compound 8, a galactose-
bearing multivalent ligand equipped with a £uorescent la-
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Figure 5. Results of B. subtilis capillary accumulation assays
using ROMP-derived glucose ligands. Buffer alone, glucose or
glucose-bearing compounds 5^7 were used as attractants in the
capillary accumulation assay. Results are shown for glucose
(black circles), 5 (red), 6 (green) and 7 (blue). Chemical structures
of the attractants are shown. Results are the average of at least
four trials performed in duplicate and error bars represent single
standard deviations.
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bel (Figure 7). When E. coli were treated with either £uo-
rescein-labeled anti-Tsr antibody or with 8, the £uores-
cence patterns observed were similar (Figure 8a,b). Both
materials bound at the poles of the bacteria (Figure 8c).
These results indicate that ROMP-derived ligands bind
speci¢cally to the bacterial chemoreceptors. To address
directly the ability of these multivalent ligands to cluster
receptors, we treated CheW mutants with both compounds.
We observed patches of anti-Tsr antibody labeled chemo-
receptors that colocalize with compound 8. This result sug-
gests that multivalent ligand 8 is responsible for the ob-
served changes in cell surface receptor organization (Figure
8d).
Our data suggest that multivalent ligands can in£uence
chemotactic responses by altering the extent of cell surface
chemoreceptor clustering. An alternative possibility is that
the multivalent ligands exhibit increases in functional af-
¢nity that lead to changes in the length of time a receptor
is occupied and/or the number of receptors that are en-
gaged. These mechanisms may contribute, yet evidence
linking changes in ligand af¢nities with chemotactic activ-
ity is lacking. Equilibrium binding constants for various
ligands often do not correlate with ligand activities in bac-
terial chemotaxis assays [34,35,50,51]. In contrast, studies
have implicated receptor clustering in chemotaxis [38^
41,46,52]. For example, it has been shown that assembled
tetramers of the chemoreceptor Tar are more active in in
vitro signaling than are individual receptors or dimers [53].
Together, our data and these results suggest that the differ-
ences in chemotactic activities for monovalent 1 versus
multivalent 3 and 4 are due to their abilities to change
the valency of receptor clusters. We propose a mechanism
in which systematic increases in ligand valency lead to
changes in chemotactic responses by the incorporation of
additional receptors into clusters (Figure 9).
Signi¢cance
Ligand valency and receptor clustering are critical compo-
nents of many cell surface processes. Understanding their
(a) (b) (c) (d) (e)
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Figure 6. Visualization of receptor reorganization by ROMP-derived arrays. E. coli AW405 (a) or RP1078 (cheW, (b)) were pretreated with
buffer alone, and E. coli RP1078 were pretreated with compounds 1 (c), 3 (d) or 4 (e) at 5 mM. The receptors were visualized using an
antibody that binds the chemoreceptors (anti-Trs antibody) [49]. Images shown are representative of bacteria from at least two independent
experiments.
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Figure 7. Structure of galactose-bearing
£uorescent multivalent ligand 8.
Fluorophore (BODIPY-TR) is shown in red.
The valency (n = 25) is calculated as
described in the Materials and methods
section.
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roles in the regulation of cellular response is important,
both for elucidating features of physiological interactions
and designing compounds to elicit desired responses. We
have generated synthetic molecules by ROMP that differ
only in ligand valency, a feature not previously available in
multivalent ligands for studying signal transduction and its
rami¢cations. We have shown that the valency of a ligand
in£uences its ability to cluster the chemoreceptors and its
ability to elicit a chemotactic response. Our results suggest
that multivalent ligands of distinct valency, such as those
described here, can be used to tune cellular responses
through changes in receptor organization. Our synthetic
route to multivalent arrays is general [54]; consequently,
the strategy can be extended to explore a diverse spectrum
of events that are mediated by receptor clustering.
Materials and methods
Generation of multivalent galactose-bearing polymers
The ROMP reaction was used to convert 1 to the series of oligomers 2^
4 as described previously [55]. Similar conditions were employed in the
synthesis of oligomers 6 and 7 [54]. Fluorescent polymer 8 was gener-
ated by speci¢c end-labeling with a bifunctional capping agent and sub-
sequent conjugation to the £uorophore BODIPY-TR [56]. The details of
the synthesis of the capping agent will appear elsewhere. Valency (n) is
an approximation of the polymer length derived from the ratio of mono-
mer to catalyst used in the ROMP reaction.
Video microscopy
E. coli AW405, which exhibit wild-type chemotactic responses, from an
overnight culture were grown in LB (Luria^Bertani broth) to an OD550 of
0.4^0.6 and then washed twice with attractant free chemotaxis buffer
(10 mM potassium phosphate buffer, pH 7.0, 10 WM EDTA). Partially
permeabilized bacteria (25 WM EDTA for 3 min at room temperature,
then quench with 50 WM CaCl2; this treatment had no effect on bacterial
chemotaxis toward galactose or 1 but was necessary for chemotaxis
toward 4, data not shown) [57] at an OD550 of 0.1 were placed under
a cover slip supported by additional cover slips in the method of Sager
et al. [44]. Bacteria were allowed to adjust to contact with the glass
surface for 1^2 min. The attractant was added to achieve the ¢nal con-
centration indicated at a 5 Wl ¢nal volume. The bacterial motion at 28³C
was recorded, and the paths were analyzed using the ExpertVision
system. Paths derived from the ¢rst 5^15 s following the introduction
of attractant were analyzed. Angular mean velocities varied approxi-
mately 14% between experiments performed on different days. Data
were analyzed using the Q and Students tests.
Capillary accumulation assay
E. coli from an overnight culture were grown in LB to an OD550 of 0.4^
0.6, washed twice with E. coli chemotaxis buffer and then partially per-
meabilized. Bacteria were resuspended in chemotaxis buffer to an
OD550 of 0.1 and utilized in the capillary accumulation assay at 30³C
for 60 min, as previously described [45]. B. subtilis OI1085 were grown
from an overnight culture in T broth (1% tryptone, 0.2 mM MgCl2, 0.5%
530 nm
(a)
590 nm
(b)
(c)
(d)
Chemistry & Biology
Figure 8. Multivalent ligands bind speci¢cally to chemoreceptors
and induce receptor clustering. Schematic represents £uorescent
8 (red, 590 nm emission maximum) bound to Trg via GGBP. Trg
also interacts with £uorescein-labeled anti-Tsr antibody (green,
530 nm emission maximum). (a) E. coli AW405 treated with
£uorescein-labeled anti-Tsr antibody as in Figure 6. (b) E. coli
AW405 treated with compound 8. (c) E. coli AW405 treated with
both £uorescent anti-Tsr antibody and 8. (d) E. coli RP1078
(cheW) treated with both £uorescent anti-Tsr antibody and 8.
Results shown are representative of those from at least two
independent experiments.
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NaCl, 0.01 mM MnCl2) supplemented with 10 mM glucose and 0.5%
glycerol, washed with B. subtilis chemotaxis buffer (10 mM phosphate
buffer, pH 7.0, 10 WM EDTA, 0.5% glycerol, 0.3 mM (NH4)2SO4) and
capillary assays were performed at a ¢nal OD550 of 0.01 at 37³C for 30
min [47]. The amount of B. subtilis accumulated was normalized to 500
bacteria accumulated towards buffer alone. The results of capillary as-
says can be in£uenced by factors other than the activity of the attractant,
such as metabolism of the substrate or toxicity [45,58]. To exclude this
possibility, we tested the ability of E. coli to utilize 1 as a sole carbon
source. These experiments revealed that 1^4 are not toxic and that
monomer 1 is not metabolized (data not shown). Data was analyzed
using the Q and Students tests.
Immuno£uorescence microscopy
E. coli AW405 or RP1078 (cheW) were pretreated with buffer alone or
with compounds 1, 3, 4 or 8 at 5 mM in a 10 Wl total volume of chemo-
taxis buffer. After a 10 min incubation at 30³C, the bacteria were ¢xed
(2% paraformaldehyde in Hepes pH 7.0, 30 min, 4³C), placed on poly-L-
lysine treated cover slips in the bottom of six-well plates, permeabilized
with methanol and labeled with anti-Tsr antibody (1:250) and £uores-
cein-labeled goat-anti-rabbit antibody (1:500) according to the procedure
of Maddock and Shapiro [49]. Anti-Tsr antibodies recognize the con-
served chemoreceptor cytoplasmic domain and are thus cross-reactive
with multiple chemoreceptors (J.S. Parkinson, personal communication).
Some binding exclusion (exclusive 530 or 590 nm £uorescence at a
pole) was seen in dual labeling experiments in which both antibody
and 8 were used. Fluorescence microscopy was performed on a Zeiss
Axioscope at 1000U using an oil immersion lens. Images were captured
using IPLab Spectra 3.2 and Adobe PhotoShop 5.0.
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